The Value of Trabectedin in the Treatment of Soft Tissue Sarcoma

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s84789
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Role of Trabectedin in the Treatment of Soft Tissue Sarcoma

OncoTargets and Therapy
OncologyPharmacology
2009English

Trabectedin in the Treatment of Patients With Soft Tissue Sarcoma

Nowotwory
Cancer ResearchOncology
2018English

BRCA1 Haplotype and Clinical Benefit of Trabectedin in Soft-Tissue Sarcoma Patients

British Journal of Cancer
Cancer ResearchOncology
2015English

Efficacy of Trabectedin in Advanced Soft Tissue Sarcoma: Beyond Lipo- And Leiomyosarcoma

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Trabectedin Plus Olaparib Has Activity in Patients With Soft-Tissue Sarcoma

Cancer Discovery
Oncology
2018English

Trabectedin: Safety and Efficacy in the Treatment of Advanced Sarcoma

Clinical Medicine Insights: Oncology
Oncology
2011English

Trabectedin for Inoperable or Recurrent Soft Tissue Sarcoma in Adult Patients: A Retrospective Cohort Study

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Treatment of Pelvic Bone and Soft Tissue Sarcoma.

Orthopedics & Traumatology
1997English

Immunotherapy in Soft-Tissue Sarcoma

Current Oncology
Oncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy